Dr. Jules Lin is a noted thoracic and surgical critical care surgeon at the University of Michigan and Rogel Cancer Center, where his areas of practice include minimally invasive and robotic surgery for the treatment of patients with lung and esophageal cancer, malignant pleural mesothelioma, and other chest wall and thoracic malignancies. Dr. Lin has
Dr. David J. Kwiatkowski is a practicing thoracic oncologist and genetic researcher with expertise in all types of thoracic malignancy. His particular interests include therapeutic targeting and personalized medicine approaches to cancer patient care. He is also a visiting scientist at the Broad Institute, where he is engaged in many cancer genome sequencing projects, including The
Dr. Bartley P. Griffith is a renowned cardiothoracic surgeon at the University of Maryland Health System and Professor of Surgery at the University of Maryland School of Medicine. He specializes in intricate and complex surgical techniques required for cardiac and pulmonary care and deploys his skill as part of the Greenebaum Cancer Center’s Mesothelioma and
When someone in your family is diagnosed with mesothelioma, it opens the door to pain, anger, heartache, and grief. But imagine the same thing happening twice in your family. That is exactly what happened to the Pond family of Australia. This week a judge awarded the couple’s daughter more than $600,000, to be paid to
Malignant mesothelioma is a rare form of cancer that afflicts approximately 3,500 Americans every year. The cancer’s tumors usually appear in the lungs, but one in five patients is diagnosed with peritoneal mesothelioma, in which tumors arise in the abdominal cavity. This aggressive malignancy is notoriously hard to treat, but mesothelioma specialists in New York
When a patient is suspected of having malignant pleural mesothelioma, physicians run through a series of diagnostic tests to either confirm or rule out the rare, asbestos-related disease. But a recent case documented by researchers at Case Western Reserve notes that traditional diagnostic tools can sometimes fall short, highlighting the need for comprehensive testing.
Pleural mesothelioma is a notoriously challenging disease. Always considered a terminal diagnosis, the rare form of asbestos-related cancer is also extremely aggressive, claiming its victims’ lives in a painfully short period. To counter this, researchers around the world are working to find therapies that extend life in a way that also improves quality of life.
Following a significant and troubling rise in mesothelioma deaths among women in their late 40s to mid-60s, trade unions in the United Kingdom have ordered a study of the presence of asbestos in the country’s school buildings. There is concern that the increase may be statistically significant among teachers who were exposed to the material.
Malignant mesothelioma is a rare form of cancer. The disease is characterized by tumors that form in the lining of the lungs or the abdomen. Treatment focuses on removing or minimizing the tumors that are identified and preventing their return or spread. New research has provided greater understanding of how cancer cells metastasize, and may
Malignant mesothelioma is notoriously resistant to traditional treatment protocols and is always considered fatal. Still, many patients live beyond statistical expectations after submitting to surgery, chemotherapy, and immunotherapy treatments. A recent study conducted at Hyogo College of Medicine found that pleural mesothelioma patients can both feel better subjectively and be in objectively better condition a